When:
February 27, 2020 @ 12:45 pm
2020-02-27T12:45:00-06:00
2020-02-27T13:00:00-06:00
Where:
200 State Office Building, Room 200
100 Rev Dr Martin Luther King Jr Boulevard.
St Paul
MN 55155
Contact:
Rep. Tina Liebling

Agenda:

Attorney General’s Advisory Task Force on Lowering Pharmaceutical Drug Prices Recommendations:
Dr. Stephen Schondelmeyer, Advisory Task Force Member
HF1246 (Morrison) Prescription Drug Price Transparency Act established, and report required.
HF4 (Lesch) Drug manufacturer or distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed.
HF1257 (Cantrell) Prescription drug benefit transparency and disclosure required.

Bills Added

Morrison
Prescription Drug Price Transparency Act established, and report required.
Lesch
Drug manufacturer or distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed.
Cantrell
Prescription drug benefit transparency and disclosure required.